Deviation – Page 101

Residue limit non-compliance during inspection prep: regulatory communication strategy

Strategies for Addressing Residue Limit Non-Compliance During Inspection Preparation In the pharmaceutical manufacturing realm, compliance with regulatory standards is paramount. During routine inspections, instances of residue limit non-compliance can be…

Tablet chipping complaint after tooling change – process vs formulation assessment

Investigating Tablet Chipping Complaints Following Tooling Adjustments in Manufacturing In the realm of pharmaceutical manufacturing, product quality is non-negotiable. A recent incident involving tablet chipping complaints after a tooling change…

Diversion risk signal during distribution: regulatory enforcement risk mitigation

Mitigating Regulatory Enforcement Risk for Diversion Risk Signals During Distribution In the intricate landscape of pharmaceutical manufacturing, the lifecycle of controlled substances is marked by an inherent regulatory complexity. The…

Microbial limits failure during stability studies: risk assessment for animal and food safety

Understanding Microbial Limits Failures in Stability Studies: An Investigation Approach In the realm of veterinary medicines, microbial limits failures during stability studies can pose significant risks not only to product…

Disintegration time failure during high-speed runs – FDA inspection observation risk

Investigating Disintegration Time Failures During High-Speed Tablet Runs Frequent disintegration time failures during high-speed tablet manufacturing not only jeopardize batch quality but also raise concerns during regulatory inspections. This article…

Diversion risk signal during DEA/FDA inspection: CAPA and security controls

Understanding Diversion Risk Signals During Inspections: CAPA and Security Controls During DEA or FDA inspections, the detection of diversion risk signals can pose substantial challenges for pharmaceutical manufacturers. Swift action…

Assay OOS in veterinary product manufacturing: risk assessment for animal and food safety

Investigating Assay OOS in Veterinary Product Manufacturing Encountering an Out of Specification (OOS) result during the assay of a veterinary product can present significant challenges in ensuring compliance with GMP…

Tablet capping observed during high-speed runs – process vs formulation assessment

Investigating Tablet Capping Events During High-Speed Production Runs Tablet capping is a critical manufacturing defect characterized by the separation or detachment of the tablet cap from the body during the…

Diversion risk signal during distribution: CAPA and security controls

“`html Understanding Diversion Risk Signals During Pharmaceutical Distribution In the highly regulated environment of pharmaceutical manufacturing, diversion risk signals represent a critical area of concern, particularly during distribution. Companies must…

Residue limit non-compliance in veterinary product manufacturing: GMP investigation and CAPA

Addressing Residue Limit Non-Compliance in Veterinary Product Manufacturing: A Comprehensive Investigation Veterinary product manufacturing is a highly regulated field where compliance with residue limits is critical to maintain product safety…

Chain of custody breach during warehousing: CAPA and security controls

Addressing Breaches in Chain of Custody During Warehousing: A Comprehensive Investigation Approach Breaches in the chain of custody during warehousing can pose significant risks to pharmaceutical integrity and regulatory compliance.…

Labeling deviation during inspection prep: regulatory communication strategy

Addressing Labeling Deviations during Inspection Preparations: An Investigative Approach Labeling deviations during the inspection preparation phase can pose significant challenges for pharmaceutical manufacturers, especially in the highly regulated domains of…